Fig. 2From: Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumoniaThe 28-day survival rate in CRAB patients treated with Carbapenem + Tigecycline or Carbapenem + Tigecycline and Sulbactam. CRAB, carbapenem-resistant Acinetobacter baumanniiBack to article page